Results 201 to 210 of about 9,855 (261)

Co-treatment of piracetam with risperidone rescued extinction deficits in experimental paradigms of post-traumatic stress disorder by restoring the physiological alterations in cortex and hippocampus.

Pharmacology, Biochemistry and Behavior, 2019
Pharmacotherapy and cognitive behavioral therapy, both fail to treat post-traumatic stress disorder (PTSD) in a considerable number of populations. The persistence of traumatic memories and deficit in extinction contributes to the failure of exposure ...
Ankit Uniyal, Raghunath Singh, Ansab Akhtar, Y. Bansal, S. P. Sah   +4 more
semanticscholar   +1 more source

DFT computational analysis of piracetam

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2014
Density functional theory calculation with B3LYP using 6-31G(d,p) and 6-31++G(d,p) basis set have been used to determine ground state molecular geometries. The first order hyperpolarizability (β0) and related properties (β, α0 and Δα) of piracetam is calculated using B3LYP/6-31G(d,p) method on the finite-field approach.
P, Rajesh, S, Gunasekaran, S, Seshadri, T, Gnanasambandan   +3 more
openaire   +2 more sources

Neuroprotective effects of zafirlukast, piracetam and their combination on L‐Methionine‐induced vascular dementia in rats

Fundamental & Clinical Pharmacology, 2019
Vascular dementia is considered a vascular cognitive impairment disease caused by neuronal degeneration in the brain. Several studies have supported the hypothesis that oxidative stress and endothelial dysfunction are the main pathogenic factors in ...
A. Fayez, Ahmed S. Elnoby, Nada H. Bahnasawy, O. Hassan   +3 more
semanticscholar   +1 more source

Effectiveness Oral Theophylline, Piracetam, and Iron Treatments in Children With Simple Breath-Holding Spells

Journal of Child Neurology, 2019
Breath-holding spells (BHS) are common nonepileptic paroxysmal events in children. This is a retrospective study to compare the effectiveness of oral theophylline, piracetam, and iron treatments in children with simple BHS.
A. Dai, A. Demiryürek
semanticscholar   +1 more source

Piracetam in chronic brain failure

Current Medical Research and Opinion, 1979
A double-blind, placebo-controlled trial was carried out on 109 aged patients with minimal or with moderate chronic brain failure to assess the effectiveness of piracetam (2.4 g per day) in preventing the progression of dementia. Patients received piracetam or placebo each for 6 weeks, the order of treatment being at random.
S, Lloyd-Evans, J C, Brocklehurst, M K, Palmer   +2 more
openaire   +2 more sources

Application of combined solid-state NMR and DFT calculations for the study of piracetam polymorphism.

Solid State Nuclear Magnetic Resonance, 2019
Piracetam, a popular nootropic drug, widely used in the treatment of age-associated mental decline and disorders of the nervous system such as Alzheimer's disease and dementia exists under normal pressure in three polymorphic forms (P1, P2 and P3) of ...
Łukasz Szeleszczuk, D. M. Pisklak, T. Gubica, Klaudia Matjakowska, S. Kaźmierski, Monika Zielińska-Pisklak   +5 more
semanticscholar   +1 more source

Piracetam and Dyslexia

Journal of Clinical Psychopharmacology, 1987
Previous research has suggested that dyslexics treated with piracetam have shown improvements in reading skills, verbal memory and verbal conceptualizing ability, feature analysis, and processing of letter-like stimuli. Two hundred twenty-five dyslexic children between the ages of 7 years 6 months and 12 years 11 months whose reading skills were ...
COLIN R. WILSHER, DAVID BENNETT, CHRISTOPHER H. CHASE, C. KEITH CONNERS, MARK DIIANNI, LYNNE FEAGANS, LEO J. HANVIK, ELAYNE HELFGOTT, HAROLD KOPLEWICZ, PHILIP OVERBY, MARK J. READER, RITA G. RUDEL, PAULA TALLAL   +12 more
openaire   +1 more source

Piracetam attenuates binge eating disorder related symptoms in rats

Pharmacology, Biochemistry and Behavior, 2018
Binge eating disorder (BED) is a stress‐related disorder characterized by acute episodes of excessive food intake. Piracetam, a nootropic agent has been reported to show several other neuropharmacological properties.
Yusuf Hussain, Sairam Krishnamurthy
semanticscholar   +1 more source

Piracetam‐induced immune thrombocytopenia

Epileptic Disorders, 2011
epd.2011.0438 Auteur(s) : Dries Deeren DDeeren@hhr.be, Lien Deleu Department of Hematology, H.-Hartziekenhuis Roeselare-Menen vzw, Roeselare, Belgium To the editor We refer to the paper of Oghlakian et al. on levetiracetam-induced thrombocytopenia (2010).
Dries Deeren, Lien Deleu
openaire   +1 more source

Piracetam

2010
Otto Benkert, Ion Anghelescu, Christoph Fehr, Gerhard Gründer, Philip Heiser, Christoph Hiemke, Christian Lange-Asschenfeldt, M. J. Müller, M. Paulzen, Francesca Regen, Axel Steiger   +10 more
  +4 more sources